Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Polycythemia Vera 2Thrombosis 1Thrombocytosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia 1Myeloproliferative Disorders 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1Glioma 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Bites and Stings 1Adenocarcinoma Of Esophagus 1

Interventions

Rituximab 2pembrolizumab 1merphos 1avelumab 1apatinib 1Zidovudine 1Valganciclovir 1Tegafur 1Mitomycin 1Methotrexate 1Leucovorin 1Hydroxyurea 1Epirubicin 1Doxorubicin 1Cisplatin 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Epstein-Barr Virus Infections × Hydroxyurea × Clear all
NCT01964755 2019-09-23

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

University of Miami

Phase 2 Terminated
6 enrolled 14 charts
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡